What is love thy lungs?
We’re challenging seniors in the greater Houston and Chicago areas to LOVE THY LUNGS by joining research studies looking to advance RSV prevention options.
Seniors aged 60 years or older are at a greater risk for severe Respiratory Syncytial Virus infections which could lead to pneumonia, hospitalizations, or even death.
DM Clinical Research is currently evaluating new study vaccines for RSV prevention in healthy adults aged 60+.
Those who qualify and choose to participate could have access to the study vaccines at no cost with no insurance required.
Compensation between $400-$800 for study-related time and travel is also available for qualified participants.
Show your lungs some love by getting involved in RSV prevention research today!
What is Respiratory Syncytical Virus (RSV)
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.
- Runny nose
- Decrease in appetite
- Spreads easily
- Circulated seasonally
- 2 in 3 adults will get reinfected within 8 months
There is no specific treatment for RSV infection, though researchers are working to develop vaccines and antivirals (medicines that fight viruses).
We can't do it alone!
Due to RSV in the U.S. each year, it is estimated that:
What's in it for You?
Become An Ambassador!
Frequently Asked Questions
Can I join this study if I’ve received a COVID vaccine?
Yes. If you received a COVID vaccine through your doctor, pharmacy, etc, you may participate. (Participants who received a COVID vaccine through clinical research, such as at DM Clinical or TCDD, cannot participate in this study.)